|
Xconomy
From Ascent Therapeutics Climbs Out of Stealth Mode with “Pepducins”:
Ascent Therapeutics Logo—
Ascent Therapeutics, based in Cambridge, MA, is developing a new class of drugs to target cell surface receptors involved in many diseases.
Underwriters and Partners
Connect with Xconomy
Xconomy’s Most Popular
Xconomy on Demand
Did you miss something? Don't despair…
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
